新生儿高血症与母亲的利托德林相关:一项回顾性研究
Kenichi Suga1, Yoshifumi Wakata2,3, Manami Suzuki1,4
1Department of Pediatrics, Tokushima University Hospital, Tokushima, Japan.
概括
母亲使用利托德林,特别是长期使用,显著增加了晚期早产婴儿新生儿高血症的风险. 这些婴儿需要密切监测这种潜在的严重情况.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 产科 产科 产科 产科 产科
背景情况:
- 之前的病例报告强调了与母乳里托德林相关的新生儿高血症.
- 对于晚期早产婴儿新生儿高血症的利托德林单一治疗的特定风险仍然不清楚.
研究的目的:
- 为了研究母乳里托德林与晚期早产婴儿 (34-36周妊娠期) 新生儿高卡血症之间的关联.
主要方法:
- 晚期早产婴儿 (2004-2018) 的回顾性队列研究.
- 婴儿与母亲暴露于利托德林的婴儿进行了对比,而对照组没有发生毒解.
- 由于缺乏足够的统计能力,排除了母亲使用硫酸的病例.
主要成果:
- 新生儿高血症发生在暴露于利托德林的婴儿中有5.7%的婴儿,而对照组的婴儿有1.8%.
- 母亲服用利托德林显著增加了新生儿高胆血症的风险 (调整后OR为3.71).
- 长期使用利托德林 (≥28天) 进一步增加了这种风险 (调整后OR为4.86).
结论:
- 在长期暴露于母体里托德林后出生的晚期早产婴儿患新生儿高血症的风险增加.
- 这些婴儿需要特别注意,并监测高卡莱米亚.
- 经过两周里托德林的使用,没有观察到高卡利米亚.
相关概念视频
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
770
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
770
Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Dysrhythmias V: Evaluating Dysrhythmias
42
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
Dysrhythmias VII: Nursing Management of Dysrhythmias
15
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
15
Antihypertensive Drugs: Potassium-Sparing Diuretics
635
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
635


